| PERIOD ENDING | 27-Sep-09 | 28-Jun-09 | 29-Mar-09 | 31-Dec-08 | | Total Revenue | 42,363 | 39,593 | 39,803 | 49,222 | | Cost of Revenue | 31,999 | 32,813 | 32,022 | 39,468 | | | Gross Profit | 10,364 | 6,780 | 7,781 | 9,754 | | | Operating Expenses | | Research Development | 2,748 | 2,514 | 1,980 | 2,703 | | Selling General and Administrative | 8,020 | 10,591 | 8,058 | 8,907 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
| (1,563) | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (404) | (6,325) | (2,257) | (293) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 366 | (208) | 14 | 862 | | Earnings Before Interest And Taxes | (38) | (6,533) | (2,243) | 589 | | Interest Expense | 470 | 350 | 182 | 150 | | Income Before Tax | (508) | (6,883) | (2,425) | 439 | | Income Tax Expense | 105 | 95 | 91 | 262 | | Minority Interest | 8 | 18 |
-
| 20 | | | | Net Income From Continuing Ops | (605) | (6,960) | (2,516) | 177 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (605) | (6,960) | (2,516) | 177 | | Preferred Stock And Other Adjustments |
-
| (4) | 4 |
-
| | | Net Income Applicable To Common Shares | ($605) | ($6,964) | ($2,512) | $177 |
|
0.02% Nasdaq 
0.33%
Income Statement
